Anesthesiologists using a technique similar to a dental freeze can improve the quality of recovery and decrease recovery time for breast cancer surgery patients, according…

Breast cancer patients with high levels of vitamin D in their blood are twice as likely to survive the disease as women with low levels of this nutrient, report University…

UT Arlington biochemists say their newly published study brings researchers a step closer to understanding how the commonly used synthetic compound bisphenol-A, or BPA, may promote…

New research from Aarhus University suggests that screening for breast cancer results in increased diagnoses of early stage cancer—but without a similarly sized decrease in the more serious…

The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized…

Breast cancer patients receiving radiotherapy showed decreased fatigue as a result of cognitive behavioral therapy plus hypnosis (CBTH), according to a study recently published in the…

New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway…

Scientists from The University of Manchester working with IBM Research have identified a key biological mechanism that for the first time explains why women…

A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the…

Young women who smoke may have an increased risk of a common type of breast cancer, according to a new study.

Researchers found that women…

Researchers from University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine have published new findings in the February issue of American Journal of Roentgenology that…

Researchers from Melbourne’s Walter and Eliza Hall Institute have discovered that breast stem cells and their ‘daughters’ have a much longer lifespan than previously thought, and are active in…

Survivors of breast cancer have a one in six chance of developing breast cancer in the other breast. But a study conducted in mice…

As perceived by both patients and doctors, the cosmetic results after “lumpectomy” for breast cancer differ for African-American versus Caucasian women, suggests a pilot study in the Plastic…

Breast cancer runs in families; however, genetic predisposition (such as being BRCA1 or BRCA2 mutation carriers) explains only a portion of this observation. Epigenetic changes (modifications in the genome that…

Researchers have discovered that low oxygen conditions can trigger the production of proteins that contribute to the spread of breast cancer cells. This is according to…

Radiotherapy (RT) after breast conserving surgery (BCS) has been shown to reduce the risk of breast cancer (BC) recurrence. However, although younger women tend to…

Women with a family history of breast or ovarian cancer should be assessed to see if those cancers could be linked to certain mutations, according to new recommendations.

Breast cancer patients experience fewer side effects while being treated with a widely used drug called an aromatase inhibitor when they get…

Remember when Angelina Jolie decided to have a double mastectomy to reduce her risk of breast cancer? The Hollywood star revealed her experience in The New York Times…

Metabolism was lost in the shadows of cancer research for decades but has recently been reclaiming some of the spotlight. Now, Mina Bissell, Distinguished Scientist with Berkeley Lab’s…

A tomato-rich diet may help protect at-risk postmenopausal women from breast cancer, according to new research accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology &…

In the first human experience with a drug that is the main metabolite of tamoxifen, promising responses were observed in woman diagnosed with aromatase inhibitor resistant, metastatic breast cancer, researchers said here.

Adding the antibody therapy ramucirumab to the chemotherapy drug docetaxel did not delay disease progression for patients with HER2-negative, advanced breast cancer, according to results of…

The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in…